3Lu Z, Breidt F Jr, Fleming H P, et al. Isolationg and charaterization of a Lactobacillus plantarum bacteriophage, ФJL-1, from a cucumber fermentation[ J ]. Int J Food Microbiol, 2003,84(2) : 225.
4Alexander S, Zemphira A, & J. Glenn morris, JR. Bacteriophage Therapy [ J ]. Antimicrobial Agents And Chenmtherapy, 2001,3 : 659.
5Richard M. Carlton. Phage Therapy: Past History and Future Prospects [ J]. Archivum Immunologiae et Therapiae Experimentalis, 1999,47,267.
8Gill JJ, Pacan, JC, Carson ME, et al. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical staphylococcus aureus mastitis in lactating dairy cattle[ J]. Antimicrob Agents Chemother, 2006, 50:2912.
9Setlow B, Hand AR, Setlow P. Synthesis of a Bacillus subtilis small, acid -solube spore protein in Escherichia coli causes cell DNA to assume some characteristics of spore DNA[J]. J Bacteriol, 1991,173 : 1642.
10Nelson D, Loomis L, Fischetti VA. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme[J]. Proc Natl Acad Sci USA,2001,98:4107.
3Weiss B D, Capage M A, Kessel M, et al. Isolation and characterization of a generalized transducing phage for Xanthomonas campestris pv. campestris[J]. J Bacteriol, 1994, 176(11): 3354- 3359.
4Canchaya C, Fournous G, Chibani Chennoufi S, et al. Phage as agents of lateral gene transfer[J]. Curr Opin Microbiol, 2003, 6(4): 417 - 424.
5Stover C K, Pham X O, Erwin A, et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen [ J]. Nature,2000, 406(6799): 959 - 964.
6Lavigne R, Burkal' tseva M V, Robben J, et al. The genome of bacteriophage ψKMV, a T7-like virus infecting Pseudomonas aeruginosa [ J]. Virology, 2003, 312(1): 49-59.
7Hendrix R W. Bacteriophage genomics[J]. Curr Opin Microbiol, 2003, 6(5): 506-511.
8Lu Z, Breidt F Jr, Fleming H P, et al. Isolation and characterization of a Lactobacillus plantarum bacteriophage, ФJL-1, from a cucumber fermentation[J]. Int J Food Microbiol, 2003, 84(2): 225 - 235.
9Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
10Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
3Sam Brook J,Russel D W.分子克隆实验指南[M].黄培堂,译.3版.北京:科学出版社,2002,463-471.
4HUI AN, DAHUA ZHANG, XIAOLING CHEN, et al. Isolation and identification of Salmonella pullorum[J]. Agricultural Science & Technology, 2012, 13(3): 661-663, 668.
5WATANABE R, MATSUMOTO T, SANO (2 Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice[J]. Antimicrob Agents Chemother, 2007,51 (2): 446-452.
6Podschun R, Ullmann U. Klebsiella spp as nosocomial patho- gens: epidemioiogy, taxonomy, typing methods, and pathogenic- ity factors[J]. Clin microbiol rev, 1998, 11(4): 589 603.
7Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial in{ections[J]. Int J Antimicrohia[ Agents, 2007, 30(2) :118--28.
8Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a labo- ratory manual[M]. 2nd ed. New York: Cold Spring Harbor La- boratory Press, 1989.
9Pajunen M, Kiljunen S, Skurnik M. Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O: 3, is related to co- liphages T3 and TT[J]. J Bacteriol, 2000, 182: 5114-20.
10Capparelli R, Parlato M, Borriello G, et al. Experimental phage therapy against Staphylococcus aureus in mice[J]. Antimicrob A- gents Chemother, 2007, 51(8) : 2765--73.
